Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial.
Sadda SR, Bradvica M, Vajas A, Sagong M, Ernest J, Studnička J, Veith M, Wylegala E, Patel S, Yun C, Orski M, Astakhov S, Tóth-Molnár E, Csutak A, Enyedi L, Choi W, Oh I, Jang H, Woo SJ.
Sadda SR, et al. Among authors: sagong m.
BMJ Open Ophthalmol. 2023 Dec 19;8(1):e001561. doi: 10.1136/bmjophth-2023-001561.
BMJ Open Ophthalmol. 2023.
PMID: 38114333
Free PMC article.
Clinical Trial.